SAMT-247

CAS No. 850715-59-2

SAMT-247( SAMT247 )

Catalog No. M16179 CAS No. 850715-59-2

SAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SAMT-247
  • Note
    Research use only, not for human use.
  • Brief Description
    SAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells.
  • Description
    SAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells; promotes covalent acetylation of Gag intracellularly, thereby blocking Gag processing and reducing infectivity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SAMT247
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    850715-59-2
  • Formula Weight
    266.32
  • Molecular Formula
    C12H14N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N)CCNC(C1=CC=CC=C1C(C)=O)=S
  • Chemical Name
    Ethanethioic acid,S-[2-[[(3-amino-3-oxopropyl)amino]carbonyl]phenyl] ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Miller Jenkins LM, et al. Nat Chem Biol. 2010 Dec;6(12):887-9.
molnova catalog
related products
  • HAR-171

    HAR-171 is a small molecule gp120-CD40 blocker that acts as a highly potent HIV entry inhibitor with IC50 of 0.43 uM against YTA48P virus.

  • Opaviraline

    Opaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.

  • Doravirine

    Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.